[144] Labcorp Holdings Inc. SEC Filing
Labcorp Holdings Inc. (LH) filed a Form 144 reporting a proposed sale of 3,903 shares of common stock with an aggregate market value of $1,059,371.39. The filing lists 83,100,000 shares outstanding and names Fidelity Brokerage Services as the broker; the sale is slated for 08/13/2025 on the NYSE.
The filing shows the securities were acquired via an option granted on 02/12/2019, with acquisition and payment dated 08/13/2025, and payment made in cash. It also reports no securities sold in the past three months for the selling person and includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.
Labcorp Holdings Inc. (LH) ha depositato un Form 144 segnalando una proposta di vendita di 3,903 azioni ordinarie per un valore di mercato complessivo di $1,059,371.39. Il deposito indica 83,100,000 azioni in circolazione e nomina Fidelity Brokerage Services come broker; la vendita 猫 prevista per il 08/13/2025 sul NYSE.
Il modulo indica che i titoli sono stati acquisiti tramite un'opzione concessa il 02/12/2019, con acquisizione e pagamento datati 08/13/2025, e pagamento effettuato in contanti. Riporta inoltre che per la persona venditrice non sono stati venduti titoli negli ultimi tre mesi e include la dichiarazione standard che il venditore non detiene informazioni negative rilevanti non divulgate sull'emittente.
Labcorp Holdings Inc. (LH) present贸 un Form 144 informando una propuesta de venta de 3,903 acciones ordinarias por un valor de mercado agregado de $1,059,371.39. El informe indica 83,100,000 acciones en circulaci贸n y nombra a Fidelity Brokerage Services como broker; la venta est谩 prevista para el 08/13/2025 en la NYSE.
El formulario se帽ala que los valores fueron adquiridos mediante una opci贸n otorgada el 02/12/2019, con adquisici贸n y pago fechados el 08/13/2025, y el pago realizado en efectivo. Tambi茅n informa que la persona vendedora no ha vendido valores en los 煤ltimos tres meses e incluye la representaci贸n est谩ndar de que el vendedor no posee informaci贸n material adversa no divulgada sobre el emisor.
Labcorp Holdings Inc. (LH)電� Form 144毳� 鞝滌稖頃橃棳 齑� 鞁滉皜臧� $1,059,371.39鞚� 氤错喌欤� 3,903欤� 毵り皝 鞓堨爼鞛勳潉 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 鞙犿喌 欤检嫕 靾橂ゼ 83,100,000欤茧 旮办灛頃橁碃 鞛堨溂氅�, 欷戧皽鞚胳溂搿� Fidelity Brokerage Services毳� 氇呾嫓頄堨姷雼堧嫟. 毵り皝 鞓堨爼鞚检潃 NYSE鞐愳劀 08/13/2025鞛呺媹雼�.
頃措嫻 鞝滌稖靹滌棎 霐半ゴ氅� 歃濌秾鞚� 02/12/2019鞐� 攵�鞐悳 鞓奠厴鞚� 韱淀暣 旆摑霅橃棃瓿�, 旆摑 氚� 歆�旮夓澕鞚� 08/13/2025鞚措┌ 歆�旮夓潃 顺勱笀鞙茧 鞚措（鞏挫鞀惦媹雼�. 霕愴暅 毵る弰鞚胳棎 雽�頃� 斓滉芳 3臧滌洈 雮� 毵る弰頃� 歃濌秾鞚� 鞐嗢潓鞚� 氤搓碃頃橁碃 鞛堨溂氅�, 毵る弰鞚胳澊 氚滍枆須岇偓鞐� 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Labcorp Holdings Inc. (LH) a d茅pos茅 un formulaire 144 signalant une proposition de vente de 3,903 actions ordinaires pour une valeur de march茅 totale de $1,059,371.39. Le d茅p么t indique 83,100,000 actions en circulation et nomme Fidelity Brokerage Services comme courtier; la vente est pr茅vue pour le 08/13/2025 sur le NYSE.
Le formulaire pr茅cise que les titres ont 茅t茅 acquis via une option accord茅e le 02/12/2019, avec acquisition et paiement dat茅s du 08/13/2025, le paiement ayant 茅t茅 effectu茅 en 别蝉辫猫肠别蝉. Il indique 茅galement que la personne vendeuse n'a pas vendu de titres au cours des trois derniers mois et inclut la d茅claration standard selon laquelle le vendeur ne poss猫de pas d'informations d茅favorables majeures non divulgu茅es concernant l'茅metteur.
Labcorp Holdings Inc. (LH) hat ein Formular 144 eingereicht und einen geplanten Verkauf von 3,903 Stammaktien mit einem Gesamtmarktwert von $1,059,371.39 gemeldet. Die Einreichung gibt 83,100,000 ausstehende Aktien an und nennt Fidelity Brokerage Services als Broker; der Verkauf ist f眉r den 08/13/2025 an der NYSE vorgesehen.
Aus dem Formular geht hervor, dass die Wertpapiere durch eine am 02/12/2019 gew盲hrte Option erworben wurden, Erwerb und Zahlung sind auf den 08/13/2025 datiert, und die Zahlung erfolgte in Bargeld. Es wird au脽erdem angegeben, dass die verkaufende Person in den letzten drei Monaten keine Wertpapiere verkauft hat, und die 眉bliche Erkl盲rung enthalten, dass der Verk盲ufer keine nicht offengelegten wesentlichen nachteiligen Informationen 眉ber den Emittenten besitzt.
- None.
- None.
Insights
TL;DR: Small-scale insider sale documented; likely immaterial to Labcorp's market capitalization given the share count disclosed.
The Form 144 documents a proposed sale of 3,903 common shares valued at $1,059,371.39, executed through Fidelity on the NYSE. Against the reported 83,100,000 shares outstanding, this sale represents a very small percentage of the float. The filing also discloses the acquisition method (option granted 02/12/2019) and cash payment, which clarifies the provenance of the shares. From a trading-impact perspective, the disclosed size and the absence of other recent sales suggest limited market impact.
TL;DR: Standard insider disclosure of an option-derived sale; governance note: filer affirms no undisclosed material information.
The Form 144 shows compliance with Rule 144 reporting for an option-based award exercised and sold on 08/13/2025. The submission names the broker and confirms cash payment, and it records no sales in the prior three months. The included representation that the seller lacks undisclosed material adverse information is the customary attestation on these notices. Procedurally, the filing is complete for the proposed transaction described.
Labcorp Holdings Inc. (LH) ha depositato un Form 144 segnalando una proposta di vendita di 3,903 azioni ordinarie per un valore di mercato complessivo di $1,059,371.39. Il deposito indica 83,100,000 azioni in circolazione e nomina Fidelity Brokerage Services come broker; la vendita 猫 prevista per il 08/13/2025 sul NYSE.
Il modulo indica che i titoli sono stati acquisiti tramite un'opzione concessa il 02/12/2019, con acquisizione e pagamento datati 08/13/2025, e pagamento effettuato in contanti. Riporta inoltre che per la persona venditrice non sono stati venduti titoli negli ultimi tre mesi e include la dichiarazione standard che il venditore non detiene informazioni negative rilevanti non divulgate sull'emittente.
Labcorp Holdings Inc. (LH) present贸 un Form 144 informando una propuesta de venta de 3,903 acciones ordinarias por un valor de mercado agregado de $1,059,371.39. El informe indica 83,100,000 acciones en circulaci贸n y nombra a Fidelity Brokerage Services como broker; la venta est谩 prevista para el 08/13/2025 en la NYSE.
El formulario se帽ala que los valores fueron adquiridos mediante una opci贸n otorgada el 02/12/2019, con adquisici贸n y pago fechados el 08/13/2025, y el pago realizado en efectivo. Tambi茅n informa que la persona vendedora no ha vendido valores en los 煤ltimos tres meses e incluye la representaci贸n est谩ndar de que el vendedor no posee informaci贸n material adversa no divulgada sobre el emisor.
Labcorp Holdings Inc. (LH)電� Form 144毳� 鞝滌稖頃橃棳 齑� 鞁滉皜臧� $1,059,371.39鞚� 氤错喌欤� 3,903欤� 毵り皝 鞓堨爼鞛勳潉 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 鞙犿喌 欤检嫕 靾橂ゼ 83,100,000欤茧 旮办灛頃橁碃 鞛堨溂氅�, 欷戧皽鞚胳溂搿� Fidelity Brokerage Services毳� 氇呾嫓頄堨姷雼堧嫟. 毵り皝 鞓堨爼鞚检潃 NYSE鞐愳劀 08/13/2025鞛呺媹雼�.
頃措嫻 鞝滌稖靹滌棎 霐半ゴ氅� 歃濌秾鞚� 02/12/2019鞐� 攵�鞐悳 鞓奠厴鞚� 韱淀暣 旆摑霅橃棃瓿�, 旆摑 氚� 歆�旮夓澕鞚� 08/13/2025鞚措┌ 歆�旮夓潃 顺勱笀鞙茧 鞚措（鞏挫鞀惦媹雼�. 霕愴暅 毵る弰鞚胳棎 雽�頃� 斓滉芳 3臧滌洈 雮� 毵る弰頃� 歃濌秾鞚� 鞐嗢潓鞚� 氤搓碃頃橁碃 鞛堨溂氅�, 毵る弰鞚胳澊 氚滍枆須岇偓鞐� 雽�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹鞚� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Labcorp Holdings Inc. (LH) a d茅pos茅 un formulaire 144 signalant une proposition de vente de 3,903 actions ordinaires pour une valeur de march茅 totale de $1,059,371.39. Le d茅p么t indique 83,100,000 actions en circulation et nomme Fidelity Brokerage Services comme courtier; la vente est pr茅vue pour le 08/13/2025 sur le NYSE.
Le formulaire pr茅cise que les titres ont 茅t茅 acquis via une option accord茅e le 02/12/2019, avec acquisition et paiement dat茅s du 08/13/2025, le paiement ayant 茅t茅 effectu茅 en 别蝉辫猫肠别蝉. Il indique 茅galement que la personne vendeuse n'a pas vendu de titres au cours des trois derniers mois et inclut la d茅claration standard selon laquelle le vendeur ne poss猫de pas d'informations d茅favorables majeures non divulgu茅es concernant l'茅metteur.
Labcorp Holdings Inc. (LH) hat ein Formular 144 eingereicht und einen geplanten Verkauf von 3,903 Stammaktien mit einem Gesamtmarktwert von $1,059,371.39 gemeldet. Die Einreichung gibt 83,100,000 ausstehende Aktien an und nennt Fidelity Brokerage Services als Broker; der Verkauf ist f眉r den 08/13/2025 an der NYSE vorgesehen.
Aus dem Formular geht hervor, dass die Wertpapiere durch eine am 02/12/2019 gew盲hrte Option erworben wurden, Erwerb und Zahlung sind auf den 08/13/2025 datiert, und die Zahlung erfolgte in Bargeld. Es wird au脽erdem angegeben, dass die verkaufende Person in den letzten drei Monaten keine Wertpapiere verkauft hat, und die 眉bliche Erkl盲rung enthalten, dass der Verk盲ufer keine nicht offengelegten wesentlichen nachteiligen Informationen 眉ber den Emittenten besitzt.
FAQ
How many Labcorp (LH) shares are being proposed for sale?
What is the aggregate market value of the shares in the LH Form 144?
When is the proposed sale of LH shares scheduled to occur?
How were the Labcorp shares acquired according to the filing?
Through which broker and exchange will the LH sale occur?
Does the filing report any sales of LH securities in the past three months?
